Key facts
- It has raised $2.9M; the latest was Seed Round in Jan 2026.
- Notable investors include University of Toronto, GrowthX Capital, University of Toronto Entrepreneurship, ventureLAB Innovation Centre, Hyperplane Venture Capital — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for MedEssist
- ·The full record, as it builds
Funding rounds
No funding rounds for MedEssist are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MedEssist
Developer of a cloud-based pharmacy care platform designed to help pharmacies simplify and personalize clinical and operational services. The company offers tools for website management, scheduling, digital care plans, communication, documentation, follow-ups, and clinical decision support that automate prescriptions, vaccines, testing, minor ailment consultations, and other clinical workflows, enabling community pharmacies and retail chains to improve efficiency, expand clinical services, and enhance patient care beyond traditional dispensing.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2018
- Employees
- 33
- Website
- medessist.com/
- Ownership
- Privately Held (backing)
MedEssist doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MedEssist shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MedEssist in its N-PORT filings yet. We sweep new filings monthly.